Cell-Cell Interaction and Hypoxic Brain Injury
细胞间相互作用和缺氧性脑损伤
基本信息
- 批准号:7133655
- 负责人:
- 金额:$ 121.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-02-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
This is a continuing Program Project, currently in year 10, to identify cellular and molecular mechanisms of hypoxic-ischemic brain injury. Research in the previous funding periods centered on excitotoxic neuron-neuron and neuron-glial interactions. The current proposal expands this scope to include the role of vascular injury and inflammation. There is growing recognition that approaches to reducing ischemic brain injury must also protect the "neurovascular unit," comprised of blood, microvascular endothelium, astrocytes, and blood-brain barrier, together with the surrounding neuroglial parenchyma. Ten closely interacting faculty investigators will pursue new directions in three research projects. In Project 1, "Ischemic tolerance and endothelial protection," Jeff Gidday will explore microvascular mechanisms underlying ischemic tolerance using cerebral endothelial cultures and a new mouse model in which repetitive hypoxic preconditioning promotes protection sustained over weeks. Stroke and other disorders of the neurovascular unit affect cerebral white matter, and in Project 2, "Mechanisms of axon injury in ischemic white matter," Mark Goldberg will use lentivirus vectors directing expression of molecular inhibitors to identify downstream pathways of axon degeneration. In Project 3, "Pathogenesis of CAA-induced vascular dysfunction," David Holtzman and Hans Dietrich will use in vivo and in situ approaches to examine effects of cerebral amyloid angiopathy on arteriolar function, an emerging cause of ischemic and hemorrhagic stroke in the elderly. These projects will be supported by the following Cores: Core A: "Administrative and statistical core", Core B: "Animal models", Core C: "Molecular neurosciences / viral vectors", and Core D: "Microscopy." The investigators share experimental approaches including in vivo and in vitro models, expertise in advanced microscopy, and a common interest in identifying new therapeutic approaches to stroke.
RELEVANCE FOR PUBLIC HEALTH: Approximately 700,000 Americans experience a stroke each year. This project examines mechanisms of brain injury in stroke. The long-term goal of this project is to identify potential new forms of therapy to reduce injury and promote recovery in stroke.
描述(由申请人提供):
这是一个持续的项目,目前是第10年,以确定缺氧缺血性脑损伤的细胞和分子机制。在之前的资助时期,研究集中在兴奋性毒性神经元-神经元和神经元-神经胶质细胞的相互作用上。目前的提案将这一范围扩大到包括血管损伤和炎症的作用。人们越来越认识到,减少缺血性脑损伤的方法还必须保护由血液、微血管内皮细胞、星形胶质细胞和血脑屏障组成的“神经血管单位”以及周围的神经胶质实质。十名密切互动的学院研究人员将在三个研究项目中寻求新的方向。在项目1“缺血耐受性和内皮细胞保护”中,Jeff Gidday将利用脑内皮细胞培养和一种新的小鼠模型来探索缺血耐受性背后的微血管机制,在该模型中,重复低氧预适应促进持续数周的保护。中风和其他神经血管单位的紊乱会影响脑白质,在项目2“缺血性白质中轴突损伤的机制”中,Mark Goldberg将使用慢病毒载体来指导分子抑制物的表达,以确定轴突变性的下游路径。在项目3“CAA诱导的血管功能障碍的发病机制”中,David Holtzman和Hans Dietrich将使用活体和原位方法研究大脑淀粉样血管病变对小动脉功能的影响,小动脉功能是老年人缺血性和出血性中风的新兴原因。这些项目将得到以下核心的支持:核心A:“行政和统计核心”,核心B:“动物模型”,核心C:“分子神经科学/病毒载体”,核心D:“显微镜”。研究人员共享实验方法,包括体内和体外模型,先进显微镜方面的专业知识,以及在确定中风新治疗方法方面的共同兴趣。
与公共健康相关:每年约有70万美国人中风。这个项目研究了中风时脑损伤的机制。该项目的长期目标是确定潜在的新治疗形式,以减少中风患者的伤害并促进其康复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Paul Goldberg其他文献
Mark Paul Goldberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Paul Goldberg', 18)}}的其他基金
UTSW Clinical Research Site for Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT)
UTSW 神经科学临床试验卓越网络临床研究网站 (NeuroNEXT)
- 批准号:
9571862 - 财政年份:2018
- 资助金额:
$ 121.01万 - 项目类别:
Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
- 批准号:
9927715 - 财政年份:2018
- 资助金额:
$ 121.01万 - 项目类别:
Network of Excellence in Neuroscience Clinical Trial (NEXT)
神经科学临床试验卓越网络 (NEXT)
- 批准号:
8241419 - 财政年份:2011
- 资助金额:
$ 121.01万 - 项目类别:
Network of Excellence in Neuroscience Clinical Trial (NEXT)
神经科学临床试验卓越网络 (NEXT)
- 批准号:
8526588 - 财政年份:2011
- 资助金额:
$ 121.01万 - 项目类别:
Network of Excellence in Neuroscience Clinical Trial (NEXT)
神经科学临床试验卓越网络 (NEXT)
- 批准号:
8709002 - 财政年份:2011
- 资助金额:
$ 121.01万 - 项目类别:
Network of Excellence in Neuroscience Clinical Trial (NEXT)
神经科学临床试验卓越网络 (NEXT)
- 批准号:
8865704 - 财政年份:2011
- 资助金额:
$ 121.01万 - 项目类别:
Network of Excellence in Neuroscience Clinical Trial (NEXT)
神经科学临床试验卓越网络 (NEXT)
- 批准号:
8339419 - 财政年份:2011
- 资助金额:
$ 121.01万 - 项目类别:
Network of Excellence in Neuroscience Clinical Trial (NEXT)
神经科学临床试验卓越网络 (NEXT)
- 批准号:
9085400 - 财政年份:2011
- 资助金额:
$ 121.01万 - 项目类别:














{{item.name}}会员




